Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
142.98
-2.44 (-1.68%)
At close: Jul 2, 2024, 4:00 PM
142.96
-0.02 (-0.01%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Novo Nordisk Employees
Novo Nordisk had 64,319 employees as of December 31, 2023. The number of employees increased by 9,134 or 16.55% compared to the previous year.
Employees
64,319
Change (1Y)
9,134
Growth (1Y)
16.55%
Revenue / Employee
$549,547
Profits / Employee
$200,871
Market Cap
628.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | 43,258 | 56 | 0.13% |
Dec 31, 2018 | 43,202 | 520 | 1.22% |
Dec 31, 2017 | 42,682 | 711 | 1.69% |
Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
Dec 31, 2015 | 40,638 | -319 | -0.78% |
Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
Dec 31, 2003 | 18,756 | 751 | 4.17% |
Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
Dec 31, 1999 | 11,994 | 345 | 2.96% |
Dec 31, 1998 | 11,649 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
NVO News
- 6 hours ago - Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices - Investopedia
- 11 hours ago - Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs - Benzinga
- 15 hours ago - Novo Nordisk must cut prices of weight-loss drug, Biden says in USA Today piece - Reuters
- 1 day ago - Novo Nordisk A/S - share repurchase programme - GlobeNewsWire
- 6 days ago - Novo Nordisk makes impairment loss of $816 mln in Q2 - Reuters
- 6 days ago - Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss - GlobeNewsWire
- 6 days ago - Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing - Fox Business
- 7 days ago - Novo Nordisk Rises as Wegovy Is Approved in China - Investopedia